102 related articles for article (PubMed ID: 7115418)
1. Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
Struck RF; Shortnacy AT; Kirk MC; Thorpe MC; Brockman RW; Hill DL; El Dareer SM; Montgomery JA
Biochem Pharmacol; 1982 Jun; 31(11):1975-8. PubMed ID: 7115418
[TBL] [Abstract][Full Text] [Related]
2. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
Noker PE; Duncan GF; El Dareer SM; Hill DL
Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumor agent 9-beta-D-arabinofuranosyl-2-fluoroadenine.
Bai L; Yamaguchi M; Tatsumi M; Kon K; Bräutigam M
J Cancer Res Clin Oncol; 1998; 124(7):367-73. PubMed ID: 9719499
[TBL] [Abstract][Full Text] [Related]
4. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeys.
El Dareer SM; Struck RF; Tillery KF; Rose LM; Brockman RW; Montgomery JA; Hill DL
Drug Metab Dispos; 1980; 8(2):60-3. PubMed ID: 6103788
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
White EL; Shaddix SC; Brockman RW; Bennett LL
Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 9-beta-D-arabinosyl-2-fluoroadenine-5'-phosphate by mice bearing P388 leukemia.
Avramis VI; Plunkett W
Cancer Drug Deliv; 1983; 1(1):1-10. PubMed ID: 6085754
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
Plunkett W; Chubb S; Alexander L; Montgomery JA
Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
[No Abstract] [Full Text] [Related]
9. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
[TBL] [Abstract][Full Text] [Related]
10. Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine.
Brockman RW; Schabel FM; Montgomery JA
Biochem Pharmacol; 1977 Nov; 26(22):2193-6. PubMed ID: 563233
[No Abstract] [Full Text] [Related]
11. Nucleoside conjugates V: Synthesis and biological activity of 9-(beta-D-arabinofuranosyl)adenine conjugates of corticosteroids.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Pharm Sci; 1984 Feb; 73(2):278-80. PubMed ID: 6707903
[TBL] [Abstract][Full Text] [Related]
12. Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells.
Sirotnak FM; Chello PL; Dorick DM; Montgomery JA
Cancer Res; 1983 Jan; 43(1):104-9. PubMed ID: 6847758
[No Abstract] [Full Text] [Related]
13. 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
Avramis VI; Plunkett W
Biochem Biophys Res Commun; 1983 May; 113(1):35-43. PubMed ID: 6860342
[TBL] [Abstract][Full Text] [Related]
14. Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.
Huang P; Plunkett W
Mol Pharmacol; 1991 Apr; 39(4):449-55. PubMed ID: 1708088
[TBL] [Abstract][Full Text] [Related]
15. Phosphorolytic cleavage of 2-fluoroadenine from 9-beta-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. A pathway for 2-fluoro-ATP production.
Huang P; Plunkett W
Biochem Pharmacol; 1987 Sep; 36(18):2945-50. PubMed ID: 3307790
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia.
Koski T; Vilpo L; Vilpo J
Leuk Res; 1999 Mar; 23(3):277-9. PubMed ID: 10071081
[TBL] [Abstract][Full Text] [Related]
17. Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
Dow LW; Bell DE; Poulakos L; Fridland A
Cancer Res; 1980 May; 40(5):1405-10. PubMed ID: 6245791
[No Abstract] [Full Text] [Related]
18. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells.
Tseng WC; Derse D; Cheng YC; Brockman RW; Bennett LL
Mol Pharmacol; 1982 Mar; 21(2):474-7. PubMed ID: 7048062
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of 9-beta-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA.
Spriggs D; Robbins G; Mitchell T; Kufe D
Biochem Pharmacol; 1986 Jan; 35(2):247-52. PubMed ID: 3942598
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
Avramis VI; Plunkett W
Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
